Dave Runkel, a 36-year-old engineer and Navy veteran, confronted a troubling health issue: he was passing blood. Despite ongoing symptoms like severe abdominal pain and loose stools for nearly a decade, doctors had dismissed his concerns. Determined to get clarity, Runkel lied about a family history of cancer to secure a colonoscopy, which ultimately revealed colorectal cancer. This diagnosis brought a grueling treatment journey, including radiation, chemotherapy, and multiple surgeries, compounded by the stress on his young family.
The rise of early-onset colorectal cancer, which has nearly doubled since 1995, puzzles scientists as people under 40, like Runkel, increasingly fall victim to it. Research is focusing on identifying who is most at risk to improve early detection. A breakthrough study from UCSD highlighted a “mutational signature” from a toxin called colibactin, produced by specific E. coli strains, which was far more prevalent in younger patients with colorectal cancer.
Efforts like The Beyond CRC Project aim to gather extensive data from young patients to unravel environmental, lifestyle, and genetic factors driving this cancer’s rise. Scientists are using advanced techniques like spatial transcriptomics and metagenomics to understand tumor microenvironments and the microbiome’s role in cancer development. These insights may pave the way for refined screening and treatment strategies while urging individuals to heed symptoms like unexplained weight loss or blood in the stool for timely medical intervention.